Skip to content

reditest® 011020184Recalls & reported problems

Redwood Toxicology Laboratory, Inc. · PANEL 11 COC/THC/OPI300/AMP/MAMP/BAR/BZO/MTD/OXY/P CP/BUP · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10858904006416), received between Jun 19, 2019 and Jun 19, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “False Positive Result” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • False Positive Result1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 19, 2019False Positive Result; False Positive Result

    IT WAS REPORTED THAT ON AN UNSPECIFIED DATE, THE CUSTOMER RECEIVED FALSE POSITIVE RESULTS ON THE MULTI-DRUG 11 PANEL SCREEN TEST. THE SPECIFIC DRUGS THAT TESTED POSITIVE AND NUMBER OF DONORS IS UNKNOWN. IT IS ALSO UNKNOWN IF CONFIRMATION TESTING WAS PERFORMED. NO TREATMENT WAS PROVIDED OR WITHHELD. TROUBLESHOOTING WAS CONDUCTED WITH THE CUSTOMER.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8712127 ↗

Other Radioimmunoassay, Tricyclic Antidepressant Drugs devices

All Radioimmunoassay, Tricyclic Antidepressant Drugs devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page